News

Angiography demonstrates a high-grade, modestly angulated stenosis (arrow) in the proximal segment of a large diagonal branch (A). Predilation performed with difficulty, and the GEC could not be advanced beyond stenosis even with “inch worming” techniques. (B). Advancement of the CrossFAST (C) beyond the proximal stent edge stenosis (a.), the position of the distal end of the outer catheter (b.), and the microcatheter tip (c.) are indicated.
Next-generation guide extension catheter delivers value during complex PCI

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 

heart surgery surgeons
AATS wants to improve research in the field of cardiothoracic surgery

The American Association for Thoracic Surgery has announced a new partnership with the Cardiothoracic Surgical Trials Network. The groups plan on working together to address current challenges in cardiothoracic surgery research.

Newsweek ranked the 50 best heart hospitals in the world
Moderate valve oversizing during TAVR boosts survival—too much may be less beneficial

Oversizing transcatheter heart valves can improve TAVR outcomes. There is still a reason to be cautious, however, especially when patients are receiving a balloon-expandable valve.

Semaglutide, the GLP-1 receptor agonist sold by Novo Nordisk under the brand names Wegovy and Ozempic, is associated with significant health benefits for patients with type 2 diabetes and peripheral artery disease (PAD), according to a late-breaking clinical trial presented at ACC.25, the annual meeting of the American College of Cardiology (ACC).
American College of Cardiology announces late-breaking clinical trials for ACC.26

The American College of Cardiology's 2026 annual meeting will include an all-time record of 60 late-breaking clinical studies.

Kit Crancer, chair of the Radiology Business Management Association Radiology (RBMA) Patient Action Network, and senior vice president of public policy for Rayus, explains RBMA's concerns over how the Trump administration's $1 trillion in cuts to Medicaid will economically impact rural hospitals.
RBMA shares concerns over major Medicaid cut impacts

"It is almost a tidal wave of change from the federal level that is going to begin impacting state legislatures across the country. I think folks should probably be aware of that,” said RBMA's Kit Crancer. 

claude anthropic
Radiologists criticize Anthropic CEO’s recent comments about the specialty

Ben White, MD, believes Dario Amodei may have “set a new record on how quickly you can be wrong about how radiology works and how it’s been affected by AI so far.”

U.S. FDA Sign
Radiology Partners’ AI business receives Breakthrough Device designation from FDA

The country’s largest imaging group announced the news March 5, with the decision applying to its Cognita Chest X-ray tool across multiple clinical indications. 

artificial intelligence in healthcare
FDA clears AI triage tool that detects acute infarcts on noncontrast CT scans

Unlike many stroke detection applications on the market, this model covers six vascular territories and mechanisms of infarct. 

mergers and acquisitions M&A consolidation puzzle business deal
Company seeks to become a ‘leader in interventional radiology’ with recent acquisition

Quantum Surgical, which specializes in minimally invasive, robotic-assisted cancer care, recently reached a deal to acquire NeuWave Medical, previously held by J&J. 

Strategic Radiology
Strategic Radiology expands into new state, adding Kentucky private practice

The coalition of independent imaging groups on March 3 announced the addition Central Kentucky Radiology PLLC and its 14 physicians. 

Thumbnail
Cyberattack on healthcare RCM vendor may have impacted 140K patients

The details stem from a report from SecurityWeek, but they’re a little fuzzy. After a 12 GB data trove was posted to the dark web, Vikor Scientific reported to HHS that there were nearly 140,000 victims. However, the source of the breach may be a third-party revenue cycle company, Catalyst RCM. 

artificial intelligence AI policy washington capitol
HHS tells employees to abandon Claude AI, as Trump feuds with developer Anthropic

The outlet NOTUS was the first to break the news, citing an internal email it obtained written by government officials. Agencies under the Department of Health and Human Services have been told to seek alternatives, mainly ChatGPT or Gemini. The shift could throw a wrench in the FDA’s plans to use Claude for speedy drug approvals. 

Around the web

Cardiovascular Business
Next-generation guide extension catheter delivers value during complex PCI

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 

Design by Adaptive Theme